ARCHIVES

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 09 | March 1, 1985

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends.

August 6, 2004

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research

February 10, 1978

UICC Grant Programs Available To Support International Activities

April 16, 1976

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

Two New Communications Contracts Approved

October 18, 1985